General Information of Drug Formulation (ID: F20281)

Formulation Name
Sitagliptin 50 mg tablet
Company
Avera McKennan Hospital; Cardinal Health; Merck Sharp & Dohme
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Sitagliptin DMGDKXN Cystic fibrosis CA25 Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Calcium hydrogenphosphate E00294 24441 Diluent
Carmellose sodium E00625 Not Available Disintegrant
Eisenoxyd E00585 56841934 Colorant
Ferric hydroxide oxide yellow E00539 23320441 Colorant
Magnesium stearate E00208 11177 lubricant
Sodium stearyl fumarate E00545 23665634 lubricant
Talc E00520 16211421 Anticaking agent; Diluent; Glidant; lubricant
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent